|
|
Posted May 1, 2009
by
|
San Diego, California
![]() |
This iReport is part of an assignment:
Tech talk |
Swine Flu Epidemic Solution
Brian Jovanovic, CEO of Bovis Pharmaceuticals, LLC, discusses viral compound BOV-23, which the company says has shown effectiveness against other influenza viruses in vivo animal tests. Bovis is optimistic that BOV-23 will be effective against the new swine flu influenza virus.
- TAGS:
- science,
- swine_flu,
- technology
- GROUPS:
- Tech and science
What do you think of this story?
iReport welcomes a lively discussion, so comments on iReports are not pre-screened before they post. See the iReport community guidelines for details about content that is not welcome on iReport.




Comments